| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Interleukin6RAAS (AngiotensinII)NFKBInflammation (BASKET)Receptor (Interleukin6 GP130)TocilizumabFibrosis| 1 | 2008 | Roles of IL-6-gp130 Signaling in Vascular Inflammation. | 
| + | - | nl | Curr Cardiol Rev 4(3):179-92 (2008) |
| 2 | 2005 | Directing transition from innate to acquired immunity: defining a role for IL-6. |
| + | - | nl | J Immunol 175(6):3463-8 (2005) |
| 3 | 2006 | Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. |
| + | - | nl | J Leukoc Biol 80(2):227-36 (2006) |
| 4 | 2006 | Interleukin-6 trans-signalling in chronic inflammation and cancer. |
| + | - | nl | Scand J Immunol 63(5):321-9 (2006) |
| 5 | 2003 | Interleukin-6 biology is coordinated by membrane bound and soluble receptors. |
| + | - | nl | Acta Biochim Pol 50(3):603-11 (2003) |
| 6 | 1996 | Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? |
| + | - | nl | Ann Surg 224(5):647-64 (1996) |
| 7 | 2007 | Decomposition of diverse litter mixtures in streams. |
| + | - | nl | Ecology 88(1):219-27 (2007) |
| 8 | 2003 | Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. |
| + | - | nl | Clin Cancer Res 9(13):4653-65 (2003) |
| 9 | 1989 | The biology of interleukin-6. |
| + | - | nl | Blood 74(1):1-10 (1989) |
| 10 | 2010 | Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor. |
| + | - | nl | Rheumatology (Oxford) 49(1):15-24 (2010) |
| 11 | 2006 | Interleukin-6 and rheumatic diseases. |
| + | - | nl | Arthritis Res Ther 8 Suppl 2(-):S4 (2006) |
| 12 | 2010 | The soluble interleukin 6 receptor takes its place in the pantheon of interleukin 6 signaling proteins: phenoconversion of cardiac fibroblasts to myofibroblasts. |
| + | - | nl | Hypertension 56(2):193-5 (2010) |
| 13 | 2010 | The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. |
| + | - | nl | Cardiovasc Res 86(2):211-8 (2010) |
| 14 | 2011 | Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. |
| + | - | nl | J Clin Invest 121(9):3375-83 (2011) |
| 15 | 2008 | Muscle as an endocrine organ: focus on muscle-derived interleukin-6. |
| + | - | nl | Physiol Rev 88(4):1379-406 (2008) |
| 16 | 2002 | Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. |
| + | - | nl | FASEB J 16(11):1335-47 (2002) |
| 17 | 2007 | Interleukin-6 and its receptor in cancer: implications for translational therapeutics. |
| + | - | nl | Cancer 110(9):1911-28 (2007) |
| 18 | 2003 | Principles of interleukin (IL)-6-type cytokine signalling and its regulation. |
| + | - | nl | Biochem J 374(Pt 1):1-20 (2003) |
| 19 | 2011 | Blocking the IL-6-STAT3 signaling pathway: potential liver cancer therapy. |
| + | - | nl | Future Oncol 7(2):161-4 (2011) |
| 20 | 2010 | Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. |
| + | - | nl | Proc Jpn Acad Ser B Phys Biol Sci 86(7):717-30 (2010) |
| 21 | 2005 | IL-6 and extracellular matrix remodeling. | 
| + | - | nl | Rev Esp Enferm Dig 97(8):575-95 (2005) |
